Maximizing Early Insights Using Immunoassays & Spectral Flow Cytometry to Guide Smarter Analytical Strategy for Product Specification & Biomarker Studies

  • Learn how early characterization supports data-driven assay selection and flexible specification setting ahead of validation
  • Discover how spectral flow enables broader marker panels to extract maximum data from limited material during early development
  • Understand how this upfront investment streamlines latestage refinement and regulatory alignment